http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102617542-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dd2a858c694b1716ed540a0e40639e97
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-36
filingDate 2012-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_177fa0b3861055315835e68a934e30cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8f0ede7402f1c5b5f2a3ea45ac05527
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7275b25dbc9ecd30864c308778ddd1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e57c42d772d5370e6e0da38cb94da80
publicationDate 2015-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102617542-B
titleOfInvention Method for preparing and purifying olmesartan intermediate
abstract The invention relates to a method for preparing and purifying an olmesartan intermediate. The preparation method comprises the following steps of: chlorinating 4,5-dimethyl-1,3-dioxa-cyclopentene-2-ketone, distilling under reduced pressure to obtain 4-chloro-4-methyl-5-methylene-1,3-dioxolane-2-ketone, and performing rearrangement reaction to generate the olmesartan intermediate; reducing the temperature to be below 50 DEG C, concentrating until a solvent is removed completely to obtain a crude product; and recrystallizing and purifying the crude product at the temperature of between -20 and 0 DEG C for 1 to 48 hours, wherein a recrystallization solvent may be one or a mixed solvent of more of an alkane solvent and an ether solvent. The preparation method is low in production cost, mild in reaction condition and easy to operate, raw materials are wide in sources, and high-content 4-chloromethyl-5-methyl-1,3-dioxa-cyclopentene-2-ketone can be obtained directly, so the method is particularly suitable for large-scale industrial production.
priorityDate 2012-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4554358-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5466811-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415828206
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421304183
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426178590
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419571304
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487106
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID158781
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8900
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11446681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415751620
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12481598
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID130881
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73824
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558802
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8058

Total number of triples: 34.